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OSTEOCLAST DIFFERENTIATION FROM HUMAN BLOOD PRECURSORS ON 
BIOMIMETIC CALCIUM-PHOSPHATE SUBSTRATES 
 
Abstract 
 The design of synthetic bone grafts to foster bone formation is a challenge in regenerative 
medicine. Understanding the interaction of bone substitutes with osteoclasts is essential, since 
osteoclasts not only drive a timely resorption of the biomaterial, but also trigger osteoblast activity. 
In this study, the adhesion and differentiation of human blood-derived osteoclast precursors 
(OCP) on two different micro-nanostructured biomimetic hydroxyapatite materials consisting in 
coarse (HA-C) and fine HA (HA-F) crystals, in comparison with sintered stoichiometric HA (sin-
HA, reference material), were investigated. Osteoclasts were induced to differentiate by RANKL-
containing supernatant using cell/substrate direct and indirect contact systems, and calcium (Ca++) 
in culture medium was measured. 
We observed that OCP adhered to the experimental surfaces, and that osteoclast-like cells 
formed at a rate influenced by the micro- and nano-structure of HA, which also modulate 
extracellular Ca++.  
Qualitative differences were found between OCP on biomimetic HA-C and HA-F and their 
counterparts on plastic and sin-HA. On HA-C and HA-F cells shared typical features of mature 
osteoclasts, i.e. podosomes, multinuclearity, tartrate acid phosphatase (TRAP)-positive staining, 
and TRAP5b-enzyme release. However, cells were less in number compared to those on plastic or 
on sin-HA, and they did not express some specific osteoclast markers. In conclusion, blood-derived 
OCP are able to attach to biomimetic and sintered HA substrates, but their subsequent fusion and 
resorptive activity are hampered by surface micro-nano-structure. Indirect cultures suggest that 
fusion of OCP is sensitive to topography and to extracellular calcium.   
 
Key-words     osteoclasts;  hydroxyapatite; differentiation; topography; ionic exchange;                        
bone resorption. 
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1. INTRODUCTION   
 
During implant integration toward a successful clinical outcome, surfaces of orthopaedic 
materials interact with host bone cells, triggering a chain of biological events where osteoclasts and 
osteoblasts are involved in the replacement of damaged bone by new bone [1].  
 Synthetic materials for bone replacement are widely tested for their osteoconduction and/or 
osteoinduction, with substrates hosting osteoblasts or osteoblastic cell lines scored as promising 
materials. But the replacement of bone substitutes with newly formed bone implies that the material 
is gradually removed to leave space for new bone tissue, and recent research has shed light on the 
close osteoclast/osteoblast cooperation for bone formation and remodelling. Osteoclasts have been 
shown to secrete products to promote osteoblast precursor recruitment and differentiation and 
thereby promote bone formation [2]. Therefore, understanding the nature of the interactions of the 
different biomaterials used as synthetic bone grafts and osteoclasts is of paramount importance.  
Osteoclasts, both from humans and mice, have been tested using in vitro protocols and shown to 
be able to resorb hydroxyapatite (HA) by imprinting pits on the HA surface [3,4]. Murine 
RAW.246.7 or mouse marrow-derived cells are largely employed in studies of osteoclasts on 
ceramics [5-7], with only a few publications addressing osteoclast differentiation of human 
monocytes on ceramic substitutes [8,9]. These studies have shown that osteoclasts are sensitive to 
different material properties, such as chemical composition and topography. However, the most 
crucial parameters of this interaction have not been fully identified. 
In this work we investigated the effect of the composition and surface topography of HA 
substrates on osteoclast differentiation of human blood precursors. Biomimetic HA substrates can 
be obtained by low-temperature setting reactions, where a calcium deficient hydroxyapatite (Ca/P 
ratio = 1.5) is formed through the hydrolysis of α-tricalcium phosphate (α-TCP) [10], which is very 
similar to the mineral phase of bone, in terms of chemical composition, crystallinity and specific 
surface area. We have previously shown that the microstructure of these materials can be reliably 
controlled by tuning the particle size of the starting powders [11,12], obtaining materials with the 
same chemistry and different surface topographies [13]. 
In addition, sintered stoichiometric HA (Ca/P ratio = 1.67) with surface topography quite 
different from that obtained in biomimetic HA was included in the study. This type of 
stoichiometric HA is also commonly used as bone filler in clinics and is typically fabricated by 
high temperature treatments. In order to better understand the effect on the cells of the ionic 
  
Human osteoclasts on calcium phosphates 
4 
exchange between the material and the cell culture medium, osteoclast precursors were also 
exposed to material extracts. 
To mimic the bone tissue microenvironment, peripheral blood mononuclear cells (PBMC) were 
isolated and induced to differentiate to osteoclasts on biomimetic and sintered stoichiometric HA 
substrates by RANKL-containing supernatants from osteoblast cultures. This method closely 
mimics the bidirectional osteoclast/osteoblast interaction occurring in vivo at the sites of bone 
remodeling [14]. 
 
 
2. MATERIALS AND METHODS 
 
2.1. Synthesis and characterisation of biomimetic HA substrates with different 
topographies 
Biomimetic HA substrates with identical composition, but different micro/nanostructural features 
were obtained by low-temperature setting of a α-TCP cement, using starting powders with different 
particle sizes, as previously reported [11].   
Briefly, α-TCP was obtained by heating in a furnace (Hobersal CNR-58), in air, an appropriate 
mixture of calcium hydrogen phosphate (CaHPO4, Sigma–Aldrich C7263) and calcium carbonate 
(CaCO3, Sigma–Aldrich C4830) at 1400 °C for 2 h followed by quenching in air. Two different 
sizes of α-TCP powder were prepared following two different milling protocols. The powder with 
larger size (coarse, C) was milled in an agate ball mill (Pulverisette 6, Fritsch GmbB) with 10 balls 
(d = 30 mm) for 15 min at 450 rpm. The powder with smaller particle size (fine, F) was first milled 
with 10 balls (d = 30 mm) for 60 min at 450 rpm followed by a second milling for 70 min at 500 
rpm with 100 balls (d = 10 mm). Precipitated hydroxyapatite (2 wt%; Alco 1.02143) was added as 
a seed in the powder. The cement’s liquid phase consisted of an aqueous solution of 2.5 wt % 
disodium hydrogen phosphate (Na2HPO4, Panreac 131679.1210). A liquid to powder (L/P) ratio of 
0.35 ml/g was used to prepare disks of 14 mm diameter and 0.25 mm high in Teflon moulds. The 
cements were allowed to set in Ringer’s solution (0.9 wt.% NaCl) for 7 days at 37 °C to obtain the 
calcium deficient HA. In addition, stoichiometric HA discs were obtained by sintering in air at 
1100 ºC for 20 h a pre-compacted mixture of CaHPO4 and CaCO3 at 50 MPa, with a calcium to 
phosphorous ratio of 1.67. Biomimetic HA samples were named HA-C and HA-F in accordance 
with the powder size used to prepare them, and the stoichiometric HA, used as a reference material 
for cell cultures, was named sin-HA. 
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The microstructure on the surface of the samples was observed by scanning electron microscopy 
(SEM, Zeiss Neon40, 5 kV). A thin gold/palladium layer was deposited on the sample surface 
through vapour deposition before analysis to enhance conductivity. The surface roughness was 
characterized by optical interferometry (Veeco Wyko NT1100), using a 50x magnification and a 
scanned area of 125 x 95 mm2. Images were processed using Vision32 software. The specific 
surface area (SSA) of the samples was determined by nitrogen adsorption (ASAP 2020 
Micromeritics) using the Brunauer- Emmett-Teller (BET) method. 
 
 
2.2 Osteoclast cultures 
 
Peripheral blood mononuclear cells (PBMC), containing the precursors of human osteoclasts, 
were isolated from buffy coats of healthy voluntary blood donors to the National Blood Transfusion 
Service. Donation was anonymous, and institutional review board (IRB) approval was not required.  
The mononuclear cells were isolated by density centrifugation using Ficoll-Histopaque gradient 
(Sigma–Aldrich), washed with phosphate-buffered saline (PBS), re-suspended in Dulbecco's 
Modified Eagle's Medium – High Glucose (DMEM, Euroclone, Milan, Italy) supplemented with 10 
% fetal bovine serum (FBS, Euroclone) (complete DMEM), and seeded for the direct and indirect 
assays.  
To induce the differentiation of osteoclast precursor (OCP) the RANKL-containing human 
osteoblast (HOB) supernatant was used [15,16].  HOB were seeded (1.5x104 cells/cm2) in 75-cm2 
tissue-culture flasks in complete DMEM medium. After reaching 90% confluence, the cell 
supernatant was collected, centrifuged at 2000g at 4 °C for 10 minutes, and stored at −80°C until 
use. In both the culture systems the OCP were re-stimulated with 25% HOB supernatant every 3 
days with a medium change along the 21-day culture period. 
 
2.2.1 Direct contact assay 
The biomimetic HA (HA-C and HA-F) and sintered HA (sin-HA) disks were placed at the bottom 
of 24 well-polystyrene culture plates (Nalge-Nunc International, Rochester, New York, USA), and 
were pre-conditioned with complete DMEM, in humidified 5% CO2 atmosphere at 37°C for 4 days. 
Then the medium was removed and 6 x 106 cells per cm2 were seeded on the preconditioned disks, 
whereas 3 x 106 cells per cm2 were seeded in the tissue culture polystyrene wells (TCPS) and used 
as controls. 
After incubation for 2 h at 37 °C in humidified atmosphere, with 5 % CO2, the non-adherent cells 
were removed, and complete DMEM supplemented with 25 % RANKL-containing human 
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osteoblast supernatant (differentiation medium) was added to adherent cells for the direct contact 
assay. 
Changes in calcium and phosphorus concentration of the culture medium in contact with the HA 
substrates, with or without cells, were determined at 317.933 and 177.95 nm respectively by 
Inducted Coupled Plasma – Optical Emission Spectroscopy (ICP-OES, Perkin-Elmer Optima 3200 
RL). Ionic concentrations were determined once a week in triplicate for a period of 21 days.   
 
2.2.2 Indirect contact assay 
The extracts of the biomimetic and sintered HA were prepared by dipping a disk in 1 ml of 
complete DMEM at 37 ºC in a humidified atmosphere with 5 % CO2. After 3 days each extract was 
collected to be used in the indirect contact assay, and new complete DMEM was added to the disk 
to keep the disk/medium proportion. The extracts were collected using this protocol every 3 days 
along the whole culture period (21 days).  
For the indirect contact assay, cells (3 x 106 per cm2) were seeded on TCPS and after 2 h the 
non-adherent cells were removed, and the adherent cells were cultured with extracts supplemented 
with 25% of RANKL-containing human osteoblast supernatant. A culture treated with the 
differentiating medium only was used as a control.  
 
2.3 Cell morphology 
 
2.3.1 Confocal microscopy 
OCPs were fixed in 3.7 % paraformaldehyde/PBS, pH 7.4, at room temperature for 20 min. After 
a rinse with PBS, permeabilization with 0.5 % Triton X-100 in PBS for 10 min at room temperature 
and staining using 1:200 Phalloidin–Tetramethylrhodamine B isothiocyanate (Sigma–Aldrich) for 
45 min in the dark, the OCP were observed by confocal microscopy (ECLIPSE E600, NIKON 
Corp.) at 520 nm excitation and 582 nm emission. 
 
2.3.2 Focused Ion Beam-Scanning Electron Microscopy (FIB-SEM) 
For FIB - SEM (Zeiss Neon 40) examination of the cells in direct contact test, the disks removed 
from the culture plates were rinsed with 0.1 M PBS and the OCP fixed with 2 % para-
formaldehyde/2 % glutaraldehyde in 0.1 M cacodylate buffer overnight at 4 ˚C. Following a rinse 
in 0.1 M cacodylate buffer, each sample was postfixed in 2 % osmium tetroxide (OsO4) for 2 h at 
room temperature. Fixed samples were then dehydrated in an ethanol series followed by hexa-
methyl-disililane drying. The dried samples were covered with a gold-palladium thin film.  
  
Human osteoclasts on calcium phosphates 
7 
After SEM observation, FIB lithography was used to examine the material underlying the cells. 
Selected cells were sectioned vertically by a Gallium ion beam at 30 keV. First, a thin layer of 
platinum (Pt) was deposited on the surface by ion-beam assisted deposition in order to reduce the 
curtaining effect and to obtain a smoother cross-section. Then, a rough milling was performed with 
a maximum current of 10 nA to quickly remove most of the material up to a depth of approximately 
20 µm nearby the region of interest. Finally, a polished cross-section was obtained by subsequently 
reducing the Gallium beam current from 2 nA down to 500 pA when approaching the Pt layer. This 
procedure reduced the ion beam damage to the sample and the redeposition effects and allowed 
observing a cross-section of the cell and the underlying microstructure without any modifications.   
 
2.4 Osteoclast recognition 
 
2.4.1 Tartrate-Resistant Acid Phosphatase and Hoechst staining 
Tartrate-resistant acid phosphatase (TRAP) positivity and multinuclearity, i.e. more than 3 nuclei 
per cell, were used to verify in situ monocytes differentiation to mature osteoclasts. For TRAP 
staining the OCP were fixed with 3 % paraformaldehyde-2 % sucrose for 30 min, permeabilized 
with Triton 0.5 % in HEPES for 5 min at room temperature, and stained using naphthol AS-BI 
phosphoric acid and tartrate solution (Acid Phosphatase kit, Sigma–Aldrich) for 60 min at 37 °C.  
Cell nuclei were stained by cell incubation with 2.25 µg/mL of Hoechst 33258 (Sigma–Aldrich) 
for 10 min in the dark. TRAP stained samples were observed by optical microscopy and the nuclei 
under fluorescence microscope at 360 nm excitation and 470 nm emission. 
 
2.4.2 Tartrate-Resistant Acid Phosphatase activity 
To quantify the cellular tartrate-resistant acid phosphatase isoform 5b (TRAP5b) activity, after 
21 days of culture the supernatants of cells grown on HA substrates and TCPS were collected, 
centrifuged at 400g for 5 min and assayed using the BoneTRAP® Assay kit (Pantec s.r.l., Torino, 
Italy), according to the manufacturer's instructions.  
The concentration of TRAP5b protein in the supernatants was determined by reading the 
absorbance at 405 nm in a spectrophotometer (Tecan Infinite F200pro, Mannedorf, Switzerland).  
Data are expressed as mean concentration (units/L) after subtraction of the corresponding cell-
free readout. 
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2.4.3 Osteoclastic gene expression 
Gene expression of the osteoclast markers cathepsin K (CTSK), Matrix Metalloproteinase-9 
(MMP-9) and vacuolar-ATPase (v-ATPase) was evaluated by Real-time PCR after 21 days of 
culture and compared to expression at seeding (day 0).  
Total RNA was extracted from cells using TRIzol® (Invitrogen, Carlsbad, CA) according to the 
manufacturer's protocol, and reverse transcribed. A260/A280 ratio of the prepared total RNA was 
always ≥1.85. Messenger-RNA expression was evaluated using a Light Cycler instrument (Roche 
Diagnostics, Indianapolis, IN) and the Universal Probe Library (Roche Applied Science).  
Probes and primers were selected using a web-based assay design software (ProbeFinder 
http://www.rocheapplied-science.com). Gene sequences and primers are reported in Table I.  
The results were normalized to the 18S ribosomal RNA (rRNA 18s) control housekeeping gene.  
 
2.5  Statistics 
Statistical analysis was performed using StatView 5.01 for Windows (SAS Institute Inc, Cary, 
NC). Mann-Whitney U test was used for the unpaired comparison of two independent variables. 
Quantitative data were expressed as an arithmetic mean plus or minus the standard error of the 
mean, and differences were considered significant at P values ≤ 0.05. 
 
3. RESULTS 
 
3.1 Material characterisation 
Biomimetic HA substrates with distinct isotropic topographies were obtained by the hydrolysis 
of α-TCP powders with different particle size distributions. Detailed characterization of the 
composition, crystallinity, compressive strength and porosity has been described in previous papers  
[10,11]. Both materials consisted of the same crystal phase, that is poorly crystalline, calcium-
deficient HA.  
SEM micrographs, as well as the images obtained by optical interferometry, are shown in Figure 
1.   
In both HA-F and HA-C substrates the surface topography was complex, composed of spherical-
like agglomerates of plate-like crystals of micrometric size (HA-C) or needle-like crystals of 
nanometric size (HA-F), resulting in a combined micro- and nanotopography, as described in detail 
in a previous publication [13].  
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HA-F developed a much finer structure than the HA-C, the average roughness (Ra) being 0.7 ± 
0.1 and 1.7 ± 0.2 µm, respectively, for HA-F and HA-C.  The SSA was approximately double for 
HA-F (33 m2/g) in comparison to HA-C (18 m2/g).  
In contrast, the surface topography of sin-HA substrates consisted of smooth polyhedral grains of 
several micrometers, connected by sintering necks with few remaining pores. Although the surface 
roughness of sin-HA (Ra = 0.6 ± 0.1 µm) was similar to that of HA-F, the SSA was significantly 
lower than that of biomimetic HA (0.54 m2/g).  
X-ray diffraction (data not shown) confirmed the purity and high crystallinity of sin-HA.  
 
3.2 Direct-contact assay  
Osteoclast precursors isolated from peripheral blood were found to attach to all the surfaces 
under assay, and osteoclasts were induced by the differentiation medium, i.e. under the influence of 
RANKL, the osteoclast differentiating factor produced by osteoblasts. In situ osteoclast 
differentiation on HA-C and HA-F biomimetic substrates was assessed by analyzing morphology, 
specific markers, and gene expression of osteoclasts. Tissue culture plastic and sin-HA, that are 
surfaces known as permissive for osteoclast differentiation, were used as control and reference 
material, respectively.  Wherever not specified, the assay was performed after 21 days of culture of 
OCP on the different substrates. 
 
3.2.1 Morphology 
The cytoskeletal actin ring of the cells, indicative of mature osteoclasts, was examined by 
confocal laser scanning microscopy on samples stained with rhodamine-phalloidin.  
A few clusters of cells, 10-20 µm in diameter, with a peripheral actin stain, were observed on 
both HA-C and HA-F substrates. However, on HA-F a higher number of clusters were observed.  
Large double actin rings with some podosomes, i.e. small actin dots, were seen for OCP on sin-HA, 
and very large (diameter: 60-250 µm) osteoclasts with double actin rings and podosome belt, were 
seen on TCPS used as a control surface (Fig. 2).  
On HA-C and HA-F different cell arrangements were seen by SEM (Fig. 3). OCP were able to 
attach on the surface of HA-C with a flat appearance (Fig. 3a), as they spread on the rough surface, 
showing many dorsal microvilli and connecting each other (Fig. 3b).  
Under the cell bodies no evident differences in HA-C microstructure were observed that could be 
associated with material resorption by the cells (Fig. 3c).  
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On HA-F a high number of OCP was seen over the material surface, with elongated morphology 
and evident nuclei, as well as cell-cell connecting filopodia (Fig. 3 d,e).  Looking at the material 
under the cell bodies, no clear changes in the underlying typical needle-like microstructure were 
seen (Fig. 3f). 
On sin-HA (reference material), many osteoclasts with spread and flattened morphology were 
formed, and active resorption pits, clearly distinguishable from the intrinsic porosity of the 
material, were seen on the sin-HA surface (Fig. 4a,b). Under such pits the material microstructure 
was changed, with typical signals of acidic degradation (Fig. 4c). 
Ultrastructural observation using SEM showed that on TCPS many osteoclasts were formed by 
fusion of OCP and displayed the typical aspect, i.e. large cells with a rough membrane (Fig. 4 
d,e,f). Osteoclasts were tightly attached to this surface, with cellular filopodia connecting adjacent 
osteoclast to get a network. Also, clusters of non fused OCP were observed.      
   
 
3.2.2 OC recognition 
Tartrate-resistant acid phosphatase (TRAP) staining and Hoechst 33258 dye for nuclei, i.e. 
typical markers of osteoclasts, were used to characterize the cells after 21 days in differentiating  
medium on the different surfaces. All the surfaces were densely populated by TRAP-positive red 
cells, with sin-HA and HA-F scoring the higher number of OCP (Fig. 5). 
The release of TRAP5b, an active enzyme degrading bone matrix proteins, is considered a 
specific marker of late osteoclast differentiation. Following enzymatic assay in the culture 
supernatants, TRAP5b was consistently released by OCP on HA-C and HA-F, as well as on sin-HA 
and TCPS (Fig. 6) with no statistically significant differences between them. After 21 days of 
culture in osteoclast differentiation medium the gene expression of CTSK, MMP-9 and v-ATPase 
was analyzed by Real-time PCR, with data normalized to the rRNA 18s control housekeeping gene. 
Gene expression by OCP at 21 days was compared to ‘day 0’, i.e. to gene expression of PBMC 
before seeding on the surfaces and differentiation induction.   
      CTSK was consistently expressed only by OCP on TCPS. Instead, a significant increase in 
MMP-9 gene expression was observed on day 21 in all the cultures, with a higher expression on 
HA-C than on HA-F. The highest expression of MMP-9 was recorded on TCPS. V-ATPase was 
already expressed at day 0, with an increase on day 21 against day 0 only for OCP on TCPS (Fig. 
7).  
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3.2.3 Ionic fluctuations in the cell culture medium 
The changes of calcium (Ca++) and phosphorus (P5+) in the culture medium in contact with HA-
C, HA-F and sin-HA substrates with and without cells is shown in Fig. 8. In sin-HA, no changes in 
calcium and phosphorus concentration were observed compared to the TCPS control. In contrast, 
biomimetic HA-C and HA-F showed a depletion of calcium and an increased concentration of 
phosphorus, being the changes more pronounced for the HA-F than for the HA-C. Calcium 
concentration was higher for all samples with cells compared to the samples without cells. The 
variation in the calcium concentration tended to decrease along the experimental time. 
 
3.3 Indirect-contact assay 
 
Each material extract supplemented with 25% of RANKL-containing osteoblast supernatant was 
added to the cell cultures every 3 days. Osteoclast differentiation was assessed using TRAP 
staining at 14 days and gene expression at 21 days. Significance of the gene expression data was 
calculated against day 0, i.e. at seeding of PBMC. 
OCP challenged with HA-C extract differentiated to osteoclasts similarly to cells cultured with 
differentiating medium only on TCPS (control) and with sin-HA extract. Some osteoclasts were 
seen in the culture challenged with the HA-F extract, too (Fig. 9). 
     As shown in Fig. 10, OCP challenged with HA-C or HA-F extracts expressed CTSK at 21 days, 
even if less than sintered-HA and TCPS, and significantly more than at time 0. MMP-9 and v-ATP-
ase, were highly expressed by OCP on sin-HA and TCPS. These genes were recorded also for HA-
C treated cells, with a value similar to those expressed at time 0. HA-F treated cells had a lower 
expression of MMP-9 and v-ATPase in comparison to time 0. 
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4. DISCUSSION                   
 
Most of the literature on in vitro calcium phosphate (CaP) materials compatibility deals with 
osteoblasts or osteoblast-like cells, as their adhesion, proliferation and function on these materials 
are taken as proofs of good bone integration [4, 17, 18]. However, a balance between osteoblastic 
and osteoclastic activities is required for a successful biomaterial therapy, as bone substitutes have 
to be resorbed with time and replaced by new bone deposited by osteoblasts. The coupling of bone 
formation to resorption, already suggested 30 years ago by the group of Baylink [19], is 
increasingly recognized as a complex dynamic process: osteoclasts produce many molecules 
affecting osteoblasts and vice-versa [20-22]. 
The release of pro-osteogenic signals coming from osteoclasts has been recently confirmed to 
occur also on CaP substrates [23-24]. Therefore, the attachment and activity of osteoclasts on CaP 
surfaces has to be seen not only for their resorptive function, but also as an essential preparatory 
step to substrate replacement by new bone [25].  
This study was aimed at verifying if blood-derived human OCP may differentiate to osteoclasts 
and resorb the substrate when plated on HA disks with different microstructures. Also, direct and 
indirect contact assays were performed to discern the effects on osteoclast formation of 1) surface-
cell interaction and 2) ion exchange potentially occurring at the HA/cell culture medium interphase. 
In both assays, osteoclast maturation was induced by osteoblast-derived differentiating medium. 
HA disks were prepared by a low temperature setting reaction, resulting in a more biomimetic 
composition, topography and crystal size than sintered HA, prepared by typical solid state reaction 
at high temperature.  
Using the direct contact system, we found that after 21 days of culture osteoclast-like cells were 
formed on all the surfaces, but their density, morphology and potential resorbing activity were 
different.  
On the control and reference surfaces, TCPS and sin-HA respectively, osteoclasts were formed, 
as shown by large, continuous actin rings at the cell periphery as seen by confocal microscopy (Fig. 
2), as well as by a large size, a flattened aspect and the cell-cell connections seen by SEM (Figs. 3 
and 4). Moreover, pits due to active resorption by osteoclasts were seen on sin-HA, with some 
aspects of acidic degradation of the material under the cells (Fig. 4). The differentiation of 
precursors to osteoclasts on TCPS and sin-HA was confirmed by the TRAP positive staining of 
multinucleated cells, as well as by the release of active TRAP5b enzyme in the medium. 
Furthermore, gene analysis showed a high expression of CTSK, MMP-9 and v-ATPase at 21 days 
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from seeding on TCPS, whereas on sin-HA only MMP-9 was consistently overexpressed compared 
to time 0. All together, these findings confirmed that the protocol adopted to induce OCP 
differentiation to mature osteoclasts was effective.  
On HA-C substrate OCP attached using actin-rich podosomes, but due to surface irregularities, a 
complete actin ring was absent. By SEM, the cells were flattened on the surface, similar to cells on 
sin-HA, and used filopodia to contact other cells and to attach to the irregular surface. Also, the cell 
surface rich in microvilli suggested an intense cell activity. TRAP positivity and multinuclearity of 
cells on HA-C, as well as TRAP5b release, confirmed that osteoclasts  differentiated on the surface, 
even if less in number compared to sin-HA. According to gene expression data, only MMP-9 was 
consistently overexpressed by osteoclasts on HA-C compared to day 0.  
After 21 days of culture on HA-F substrate a very high number of OCP attached using actin-rich 
podosomes, likely due to the needle-like microstructure of the surface. By SEM it was observed 
that the HA-F samples were covered by many spindle-shaped cells which connected each other. 
TRAP and nuclei staining also showed a high density of cells with an elongated morphology, with 
only a few osteoclast-like cells. Despite the large number of attached cells, the low gene expression 
levels confirmed the paucity of mature osteoclasts seen with TRAP staining.  
Using the indirect contact assay, we found that HA-C-treated OCP generated mature osteoclasts 
and expressed CTSK, MMP-9 and v-ATPase genes, following the same trend than sin-HA-treated 
OCPs, even if with a lower expression level. Less differentiated osteoclasts were seen in the 
cultures treated with HA-F extract, which also scored the lowest osteoclast gene expression. 
It is known that one of the main surface features affecting cell attachment is topography, as 
shown in a number of studies, and a certain degree of roughness has been shown to positively affect 
osteoblasts  [26] and osteoclasts [27] adhesion and/or differentiation. 
Likewise, our results show that the cell-cell fusion, required for osteoclast formation, as well as 
the formation of a good sealing ring to resorb the substrate, are strongly affected by the material 
topography. 
In our study, the chemistry of the two biomimetic HA substrates is equivalent. In contrast, 
surface topography is clearly different, with HA-F having a smaller roughness and a higher SSA 
than HA-C, and both having a different topography compared to sin-HA used as a reference.  
These features have been shown to affect protein adsorption onto the surface [12], and also the 
response of osteoblast-like cells [13]. Therefore, it is likely that also osteoclast differentiation and 
activity is modulated by these parameters, even if osteoclasts show a certain degree of ‘rugophilia’ 
[28].  
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Although a number of results of our study point at the differentiation of OCP to osteoclasts on 
the biomimetic HA surface, they are less in number and with different morphology compared to 
mature osteoclasts developed on sin-HA or TCPS.    
This is not surprising, as osteoclast formation is the result of a high density of confluent OCP 
which fuse together [29, 30]. We suggest that the inability to migrate, fuse and form a stable actin 
ring (and a sealing zone), due to the plate- and needle-shaped microstructure of HA-C and HA-F 
surfaces, would prevent osteoclast-like cells to become mature osteoclasts driving consistent 
signals of resorption.  
In our hands, podosome formation was observed on both the biomimetic HA surfaces, but these 
structures do not further fuse to form large typical actin rings.  
As discussed by Costa-Rodrigues et al., even if it has been shown that rougher surfaces can 
support a high degree of osteoclast development when it is mediated by soluble factors (as in our 
study), material steric hindrance might become a problem for cell-to-cell interactions, and, 
noticeably, for cell fusion [28]. In another study an inverse linear correlation between the number 
of actively resorbing osteoclasts with surface microporosity of β-TCP was demonstrated, but rabbit 
Oc and not human PBMC were tested in such a study  [31]. That coarse or highly irregular surfaces 
may hinder osteoclast attachment and/or differentiation, while surfaces with a ‘low’ roughness 
allow both processes,  has been confirmed by other studies. Using human PBMC cultured on 
carbonated hydroxyapatite (CA), hydroxyapatite (HA) and b-tricalcium phosphate (TCP) with 
similar roughness, i.e. Ra = 0.5–0.6 um, osteoclasts were shown to adhere and differentiate into 
giant multinuclear TRAP-positive cells on every type of surface, even if with more ‘mature OC on 
CA [32]. Davison [23] showed that the survival, differentiation, and resorbing function of human 
osteoclasts was promoted on beta-tricalcium phosphate (TCP) with a low surface roughness, i.e. 
Ra= 0.158 um, while  TCP with Ra= 1.597 um impeded OC survival and resorption. Accordingly, 
in another study ‘a disrupted F-actin organization, with individual podosomes, and podosome 
clusters and belts along the cell periphery’, as well as  ‘less TRAP-positive staining on HA surfaces 
with increased levels of complexity and roughness’ were displayed by osteoclasts on 2um-rough 
HA surfaces [33]. Moreover, surface irregularities at the micrometer scale may hamper the 
formation of a sealing zone, too, by interrupting the OC matrix adhesiveness [34].  
Human osteoclast precursor cells are sensitive to nano-structures, too: when cultured on three 
topographically different hydroxyapatites, OC have been shown to react differently to micro- vs 
nano-structured HA surfaces, the latter appearing less attractive to osteoclastic differentiation and 
function, compared to a microsized grain topography [35]. 
  
Human osteoclasts on calcium phosphates 
15 
Therefore, focusing on human osteoclast precursors only, apparently their adhesion and 
differentiation preferentially occur on CaP-based substrates with a ‘moderate’ surface roughness at 
the microscale.  
Other material and surface features do affect osteoclast formation and activity. 
A significant correlation between initial material-dependent changes in the pH of culture 
supernatants and material resorbability, with effects on osteoclast multinuclearity and material 
resorption has been demonstrated by Keller et al. [8].  
Since osteoclasts have also been recognized as ‘mechanosensitive’ cells, which are able to sense 
rigidity of the substrate, a different stiffness of the substrates may regulate osteoclastogenesis [36], 
and also resorbability, as shown by Kruppke [25], plays a major role in OC response in vitro. 
In our study, the surface pre-conditioning with medium prior to cell seeding prevented initial 
excessive pH changes, and the stiffness of the substrates was not assessed.  
As a matter of fact, the variety of osteoclast type, CaP composition, submicro- and micro-structure, 
physical parameters and in vitro models hinder a comprehensive and definitive understanding of 
the osteoclast/material interaction [37].  
We suggest that in our system on biomimetic HA surfaces a number of mononuclear cells fused 
together to form osteoclast-like cells, but final maturation to functional osteoclasts was not always 
reached due to topographical reasons, that is podosome fusion to organized actin ring and sealing 
zone formation were hampered by the irregular surface structure. A similar mechanism was 
described by Addadi et al., who observed that ‘the assembly of the basic adhesion unit (i.e. the 
podosome) in osteoclasts is intrinsically regulated, irrespective of the particular adhesive surface 
used. However, further development of podosomal super-structures is surface-sensitive’ [38].  
Indeed, this ‘irregular’ osteoclast morphology may in turn cause the low resorption activity 
recorded in our study. Moreover, the finding of osteoclast-like cells on biomimetic HA surfaces 
does not necessarily imply that they are active. The inability to seal a zone to be resorbed may 
explain the absence of evident resorption pits on the biomimetic HA, while this was seen on 
sintered-HA. According to Geblinger D. et al. on bone ‘the resorption lacuna must be well defined 
and sufficiently stable over time to allow resorption to occur’ [39]: this is rather unlikely to occur 
on our microstructured biomimetic surfaces, while on sin-HA the surface allowed for OCP fusion 
and resorptive activity with pit formation.  
It is interesting to note, regarding the finding of no clear resorptive activity for HA-C and HA-F, 
that osteoclasts, irrespective of their bone resorption activity, are able to produce bone anabolic 
signals to osteoblasts [40]. Therefore, it cannot be excluded that the different populations of 
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osteoclasts, resorbing and non-resorbing ones, present on biomimetic HA materials could cooperate 
with osteoblasts to trigger new bone formation. 
Of note is also the depletion of calcium and the release of phosphate in the culture medium 
produced by biomimetic HA, as revealed by ICPS-OES measurements (Fig. 8): this finding has 
already been shown in previous papers [13, 41,42] and is related to the calcium deficiency and high 
SSA of the biomimetic HA.  In a previous work [41] we investigated the ionic reactivity of 
biomimetic HA in DMEM, finding also an uptake of calcium and a release of phosphate. The 
uptake of calcium can be associated to the maturation process of the calcium deficient biomimetic 
HA (Ca9(PO4)5(HPO4)OH, with Ca/P molar ratio 1.5), to stoichiometric HA (Ca10(PO4)6(OH)2, 
with Ca/P molar ratio 1.67) that is more thermodynamically stable [43,44]. The release of 
phosphate can be attributed to the replacement of phosphate ions with other ions available in the 
cell culture medium, typically carbonate, as proven by the presence of carbonate bands in the FTIR 
spectra of biomimetic-HA samples after immersion in DMEM [41]. This ion exchange process is 
amplified by the high SSA of the biomimetic materials, as well as by the presence of non-apatitic 
domains on the crystal surface of nanoapatites, giving them a higher reactivity than that of sintered 
HA [43,44]. Sin-HA, which is stoichiometric and has a lower SSA, did not induce variation in the 
ionic composition of the cell culture medium. In the presence of cells, higher levels of calcium 
were recorded in the cell culture medium, which could be caused by a reduction of the surface 
exposed, which is able to uptake calcium from the medium in the case of biomimetic HA. 
Furthermore, the differences in SSA between HA-C and HA-F produced differences in the extent 
of ionic exchanges. In our hands HA-F, with higher SSA, was subtracting more calcium from the 
microenvironment than HA-C. This could be an additional potential reason for the different 
behaviour of the two biomimetic HA regarding osteoclast formation and activity.  
Concerning the gene expression results, in the direct contact assay MMP-9 was expressed by 
OCP on all the HA surfaces, while no CTSK and v-ATPase expression was found (compared to 
day 0). This did not happen for osteoclasts on TCPS, which had a regular morphology, with evident 
TRAP staining and a lot of nuclei, and high expression in comparison to day 0 of CTSK, MMP-9 
and v-ATPase, that are all the features shared by mature osteoclasts.  Comparing HA-C and HA-F 
in both systems (direct and indirect), apparently gene expression for HA-C is always higher than 
with HA-F.  We hypothesize that the lower calcium concentration in the HA-F culture systems 
compared to HA-C could have differentially regulated gene expression and osteoclast formation. 
This may be supported by the gene expression results with extracts, where CTSK, MMP-9 and v-
ATPase were expressed by OCP on sin-HA and TCPS, where no change in calcium concentration 
was recorded, with often higher expression in sin-HA than TCPS. 
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It is known that calcium ions (Ca++) affect osteoclast differentiation and function. Osteoclasts 
and their progenitors show a cell membrane calcium receptor [45], and intracellular calcium is 
tightly regulated by calcium entry from the extracellular fluid, and a mechanism involving Ca++ and 
calcineurin leads to osteoclast differentiation [46,47]. Also, extracellular calcium concentration has 
been found to signal for osteoclasts survival and differentiation by modulation of the cytosolic Ca++ 
levels [48,49], but the role of  calcium signaling in osteoclasts is still under intense study [50,51].  
As reported by the group of Brandi, on the active bone surfaces only modest and gradual changes 
of Ca2+, ranging from 0.5 mM during formation to ≥2 mM during resorption, occur, and these 
values are very close to the calcium oscillations detected in our study by ICP-OES in the direct 
contact assay [45]. Therefore, we do not expect a major effect of calcium on the behaviour of 
osteoclasts in our protocol. 
The effect of phosphate on osteoclasts is nearly unknown. An in vivo study on phosphate 
metabolism in ADP P2Y13 receptor-knockout mice demonstrated that young mice with 16 % 
higher serum phosphorous level compared to mature mice had 73 % fewer osteoclasts [52]. 
Furthermore, it was observed that soluble inorganic polyphosphates prevent the differentiation of 
OCP to the mature osteoclasts by inhibiting the phosphorylation of the IκBα kinase and the 
expression of TRAP [53], and extracellular  inorganic  phosphate dose-dependently reduced 
RANKL-induced osteoclastic differentiation of monocyte precursors [54]. 
The results of this study improve our understanding of the fundamental mechanisms involved in 
osteoclastic differentiation mediated by calcium phosphate materials. 
We showed that the in situ differentiation of OCP into osteoclasts points at a major role of 
topography, which in turn influences ionic exchange, as higher ionic fluctuations are produced in 
materials with larger SSA.  
In static culture systems, any ionic fluctuation can markedly influence cell response, making it 
difficult to translate the results to the in vivo scenario, where fluid circulation buffers ionic 
fluctuations. Moreover, it has to be considered that when cells are cultured directly on the material 
they will sense the local concentration in the close vicinity of the surface, which is probably 
different from the average ionic concentrations measured in the cell culture medium and found in 
the extracts. This adds a degree of complexity in the interpretation of the results. 
In our system we found that the materials with rougher surface topography, which in turn results 
in calcium depletion from the medium, may hamper osteoclast formation in vitro, leading to a 
lower in vitro degradation of the biomimetic HA substrates (HA-C and HA-F). This is apparently 
in contrast with the fact that, due to their calcium deficiency and small crystal size, they are more 
soluble than crystalline stoichiometric HA, and indeed faster resorption in vivo has been 
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demonstrated [55]. Additionally, in previous works we have demonstrated that bone formation 
elicited by biomimetic HA biomaterials is preceded by osteoclastic resorption, which leads to a 
synchronized timing of bone formation and material degradation [55,56].  
This is just another example of the need to be cautious when translating in vitro results to the  in 
vivo performance, where many other factors come into play [57,58]. 
Indeed, the in vivo complexity of the osteoblast-osteoclast interaction on surfaces, in terms of 
timing, intensity, signal recognition, receptor activation, molecular pathways, not to mention 
microenvironmental pH, ion oscillations and interactions with other cells, are hard to simulate in 
vitro. Nonetheless, the in vitro culture protocols provide informative responses and OB-OC co-
culture are a good model to study the bi-directional cooperation of osteoclasts and osteoblasts.  
That osteoclast-osteoblast paracrine signaling is a crucial part of the bone remodeling process and 
should not be hindered in the treatment of bone diseases is a largely accepted concept [59], and this  
increasing knowledge should be taken into account when testing new drugs known to affect bone 
coupling or designing tissue engineering strategies for bone [37]. 
 
 
5. CONCLUSION 
This in vitro study investigated osteoclast formation from human blood-derived osteoclast 
precursors induced to differentiate after seeding on HA materials with different surface structure or 
after challenge with their extracts. 
In our experimental system the biomimetic HA-C and HA-F materials, with rough and porous 
surfaces and high SSA were permissive surfaces for OCP attachment and survival. Subsequent 
fusion and resorptive activity were partially hampered by surface micro- and nano-structure. 
Nonetheless, osteoclast-like cells and osteoclasts were able to differentiate from peripheral blood 
mononuclear cells onto calcium phosphates in 3 weeks, showing TRAP activity, even if no 
evidence of resorption activity was found. In contrast, the smoother and less reactive surface of sin-
HA better allowed osteoclast formation and activity, producing clear resorption pits on the surface. 
The comparison between direct and indirect cultures suggests that OCP are not only sensitive to 
topography, but also to the ionic exchanges in the surrounding medium.  
In conclusion, a comprehensive understanding of the physiological effect and micro-
environmental changes derived from CaP engraftment in bone, including bioactivities along with 
biocompatibility, is mandatory in considering potential usage in patients. 
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CAPTIONS 
 
Fig. 1 Scanning electron micrographs and optical interferometry images of HA-C (a-c), HA-F (d-
f) and sintered-HA (g-i), showing the microstructure and surface topography of the samples. 
 
Fig. 2: Rhodamine-phalloidin staining of actin in OCP cultured for 21 days in direct contact with 
HA substrates and TCPS. Small actin dots are indicated by arrowheads (a: HA-C; b: HA-F; c: sin-
HA; d: TCPS, scale bar= 20 micrometers).     
 
Fig. 3  Scanning electron micrographs showing the morphology of OCP cultured on biomimetic 
HA-C (a,b,c) and HA-F (d,e,f). Top row: spread and flattened cells (arrows) with connections 
between them and some fusion (a,b). FIB cut showing the HA-C microstructure below a 
representative cell (c). Bottom row: spindle-shaped cells with evident nuclei (arrows) and filopodia 
connections between them (a, b). FIB cut showing the HA-F microstructure below a representative 
cell (c).    
 
Fig. 4. Scanning electron micrographs showing the morphology of osteoclasts formed on sin-HA 
(a,b,c) and TCPS (d,e,f). Top row: (a) spread and flattened osteoclasts (arrowheads) together with 
two resorption pits (yellow arrows) and three pores typical of sintered materials (+); (b) FIB cut 
showing the sin-HA microstructure below a representative osteoclast (osteoclast edges are marked 
by a red line); (c) Boundary between the pit produced by osteoclast and the original sin-HA surface 
(area within the square in a). Original sin-HA structure is indicated by * and the degraded material 
is indicated by arrows.  Bottom row: on TCPS fused OCP form large osteoclasts with a dorsal 
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roughness and cellular processes connecting the osteoclasts to the surface and to other osteoclasts. 
Many non fused OCP are also seen.      
 
Fig. 5 TRAP-Hoechst stained OCP at 21 days of culture in differentiating medium on different 
substrates. Arrowheads point at TRAP-positive multinucleated cells, which were considered as 
osteoclasts (a,b: HA-C; c,d: HA-F; e,f: sin-HA; g,h: TCPS). Scale bar=10 micrometers. At high 
magnification (bottom row) some osteoclasts were seen among cells cultured on HA-C, even if less 
than those recognised in the TCPS and sin-HA cultures. On HA-F the cells showed a fibroblast-like 
morphology and differentiated osteoclasts were barely observed.                                                                                                                  
 
Fig. 6. Release of tartrate-resistant acid phosphatase 5b (TRAP5b) by osteoclasts on the different 
surfaces at 21 days of culture (units per liter). 
 
Fig. 7 Gene expression of the osteoclast markers cathepsin K (CTSK), Matrix Metalloproteinase-
9 (MMP-9) and vacuolar-ATPase (v-ATPase) by OCP at 21 days on the different surfaces. 
 
Fig. 8. Calcium (left) and phosphorus (right) concentration in the cell culture medium after 
exposure to the HA disks with cells (wC) and without cells (woC) in periods of 7 days until a total 
of 21 days. The Ca++ and P5+ concentration of medium in contact with TCPS is included as control. 
 
Fig. 9     TRAP staining of OCP challenged with extracts for 14 days. Arrowheads point at TRAP-
positive multinucleated cells, which were considered as osteoclasts (a: HA-C; b: HA-F; c: sin-HA; 
d: TCPS). Scale bar=10 micrometers.  Many large  osteoclasts were seen among cells cultured on 
HA-C, similar to those recognised in the TCPS and sin-HA cultures. On HA-F OCP had a 
fibroblast-like morphology and differentiated osteoclasts were barely observed.  
 
Fig. 10 Gene expression of the osteoclast markers cathepsin K (CTSK), matrix metalloproteinase-
9 (MMP-9) and vacuolar-ATPase (v-ATPase) by OCP at 21 days of exposure of OCP to the 
different extracts. 
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HUMAN OSTEOCLASTS on CaP SURFACES 
 
 
 
 
 
TRAP-positive osteoclasts 
(14 days) 
human blood-derived 
osteoclast precursors 
time 0 
micro-nano-porous calcium phosphate surfaces 
RANKL+ supernatant 
  
Gene name Gene ID Forward Reverse 
18S ribosomal RNA rRNA 18s 5′-GCAATTATTCCCCATGAACG-3′ 5′-GGGACTTAATCAACGCAAGC-3′ 
Cathepsin K CTSK 5′-GGATATGTTACTCCTGTCAAAAATCA-3′ 5′-TGCCAGTTTTCTTCTTGAGTTG-3′ 
Matrix 
metallopeptidase 9 
MMP9 5′-GAACCAATCTCACCGACAGG-3′ 5′-GCCACCCGAGTGTAACCATA-3′ 
Vacuolar- ATPase V-ATPase 5′-ATGGGGCCTCAGAGAGGA-3′ 5′-GGCACCTGCCACAAAGTT-3′ 
 
Table 1. Primer sequences of target genes 
  
  
 
OSTEOCLAST DIFFERENTIATION FROM HUMAN BLOOD PRECURSORS ON BIOMIMETIC CALCIUM-
PHOSPHATE SUBSTRATES 
 
STATEMENT OF SIGNIFICANCE 
 
The novelty of the paper is the differentiation of human blood-derived osteoclast precursors,  
instead of mouse-derived macrophages as used in most studies, directly on  biomimetic micro-nano 
structured HA-based surfaces, as triggered by osteoblast-produced factors (RANKL/OPG), and 
influenced by chemistry and topography of the substrate(s). Biomimetic HA-surfaces, like those 
obtained in calcium phosphate cements, are very different from the conventional calcium phosphate 
ceramics, both in terms of topography and ion exchange. The role of these factors in modulating 
precursors’differentiation and activity is analysed. The system is closely reproducing the 
physiological process of attachment of host cells and further maturation to osteoclasts toward 
resorption of the substrate, which occurs in vivo after filling bone defects with the calcium 
phosphate grafts. 
 
